Optinose Inc (OPTN)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | HEALTH CARE SERVICES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Peter K. Miller |
| Employees: | 190 |
| Web site: | optinose.com |
|
1020 STONY HILL ROAD, SUITE 300, YARDLEY, PA, 19067
267-364-3500
| |
Are you looking for this stock instead?
| Date | Ratio |
|---|---|
| 2024-12-31 | 1:15 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
OptiNose, Inc. focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. Onzetra Xsail, a powder EDS device, is in Phase IIIb clinical trial.
Please log in first to see chart